Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating baclofen for management of gastroesophageal reflux disease symptoms in patients who do not respond to proton pump inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

Sponsor: Adnan Imtiaj Rahul | Conditions: GERD - PPI Non-responders | Phase 2, Phase 3 | Status: RECRUITING